Acadian Asset Management
DNLI icon

Acadian Asset Management’s Denali Therapeutics DNLI Stock Holding History

Acadian Asset Management’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,749
Closed -$80K – 1758
2024
Q3 		$80K Buy
+2,749
New +$68.1K ﹤0.01% 1667
2022
Q1 		– Sell
-11,805
Closed -$526K – 1670
2021
Q4 		$526K Buy
11,805
+957
+9% +$45.3K ﹤0.01% 995
2021
Q3 		$547K Sell
10,848
-15,906
-59% -$896K ﹤0.01% 1014
2021
Q2 		$2.1M Buy
26,754
+20,817
+351% +$1.29M 0.01% 698
2021
Q1 		$339K Buy
+5,937
New +$397K ﹤0.01% 1326
2019
Q3 		– Sell
-11,650
Closed -$241K – 1902
2019
Q2 		$241K Buy
11,650
+6,728
+137% +$151K ﹤0.01% 1181
2019
Q1 		$114K Buy
+4,922
New +$103K ﹤0.01% 1481

Other funds holding DNLI

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $29.7B AUM 13.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return